Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH, a prominent player in the global healthcare landscape, is headquartered in Frankfurt, Germany. Founded in 1908, the company has established itself as a leader in the fields of aesthetics, neurology, and dermatology, with a strong presence across Europe, North America, and Asia. Merz is renowned for its innovative products, including the popular Belotero® and Xeomin® brands, which cater to the growing demand for non-surgical aesthetic treatments. The company’s commitment to research and development has led to significant advancements in therapeutic solutions, positioning it as a trusted name in the pharmaceutical industry. With a rich history and a focus on enhancing patient outcomes, Merz Pharmaceuticals continues to achieve notable milestones, solidifying its reputation as a pioneer in aesthetic and therapeutic medicine.
DitchCarbon Score
How does Merz Pharmaceuticals GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merz Pharmaceuticals GmbH's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merz Pharmaceuticals GmbH's reported carbon emissions
Merz Pharmaceuticals GmbH, headquartered in Germany (DE), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions, enhancing energy efficiency, and investing in renewable energy sources. As the industry evolves, Merz Pharmaceuticals may align with these trends to address climate change and reduce its environmental impact. Further information on their climate commitments or future initiatives may be forthcoming as the company develops its sustainability strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merz Pharmaceuticals GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
